Dr Bernat Crosas, IBMB-CSIC Researcher and head of the Regulation of the proteasome group giving a conference for Residència d’Investigadors

08/03/2021 │ 

Talk within the cycle of conferences Monday of Science: Global Health _ March.
the title of the talk is New generation of PROTAC for the treatment of Covid-19.

New technologies in diagnosis and therapy have been key to addressing the Covid-19 pandemic, from nanotechnology by diagnostic systems to mRNA-based vaccines. In our project, we introduce a new generation of proteolytic chimaeras (or Protacs) to block complications arising from infection. Protacs act as degrading agents for target proteins, showing great projection in cancer and, now, in infectious processes. We are currently developing a new type of protac that eliminates a key factor for virus multiplication in our cells.

*No video

Link to Residència d’Investigadors